176 related articles for article (PubMed ID: 31948249)
1. Histopathological and clinical features of molar pregnancy.
Heřman J; Rob L; Robová H; Drochýtek V; Hruda M; Pichlík T; Kujal P; Drozenová J
Ceska Gynekol; 2019; 84(6):418-424. PubMed ID: 31948249
[TBL] [Abstract][Full Text] [Related]
2. [Regression of hCG in various types of molar pregnancies--clinical course and prognosis].
Rob L; Robová H; Pluta M; Kulovaný E; Hrehorcák M; Chmel R; Schlegerová D; Kodet R; Macek M
Ceska Gynekol; 2001 Jul; 66(4):230-5. PubMed ID: 11569415
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
5. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
6. Partial hydatidiform mole.
Hossain N; Muzzafar N; Soomro N
J Coll Physicians Surg Pak; 2005 Jan; 15(1):50-1. PubMed ID: 15670529
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
9. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy.
Lage JM; Mark SD; Roberts DJ; Goldstein DP; Bernstein MR; Berkowitz RS
Obstet Gynecol; 1992 Mar; 79(3):403-10. PubMed ID: 1371185
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
13. Partial hydatidiform moles: a review.
Watson EJ; Hernandez E; Miyazawa K
Obstet Gynecol Surv; 1987 Sep; 42(9):540-4. PubMed ID: 2443883
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of some hematological parameters for non-invasive and invasive mole pregnancies.
Abide Yayla C; Özkaya E; Yenidede I; Eser A; Ergen EB; Tayyar AT; Şentürk MB; Karateke A
J Matern Fetal Neonatal Med; 2018 Feb; 31(3):271-277. PubMed ID: 28093002
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in complete hydatidiform mole.
Bae SN; Kim SJ
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
[TBL] [Abstract][Full Text] [Related]
16. Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies.
Koc S; Ozdegirmenci O; Tulunay G; Ozgul N; Kose MF; Bulbul D
Int J Gynecol Cancer; 2006; 16(2):940-3. PubMed ID: 16681793
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of glycophorin-A in comparison with P57 immunohistochemical staining method in differentiating complete and partial molar pregnancies.
Nili F; Babazadeh S; Sarmadi S; Ameli F; Saffar H
Ann Diagn Pathol; 2021 Aug; 53():151769. PubMed ID: 34146830
[TBL] [Abstract][Full Text] [Related]
18. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
[TBL] [Abstract][Full Text] [Related]
19. The impact of pre-evacuation ultrasound examination in histologically confirmed hydatidiform mole in missed abortion.
Tang Y; Zhu C; Zhu C; Liang F; Lee A; Yao X; Chen Q
BMC Womens Health; 2020 Sep; 20(1):196. PubMed ID: 32912152
[TBL] [Abstract][Full Text] [Related]
20. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
Mundangepfupfu T; Waseem M
J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
